Factors affecting renal microvascular blood flow in rat hyperdynamic bacteremia.
To determine whether angiotensin II and alpha-adrenergic activity contribute to the mechanism of impaired renal microvascular blood flow during hyperdynamic live Escherichia coli (E. coli) bacteremia, we used in vivo video microscopy in the chronic unilateral hydronephrotic kidney of decerebrate male Sprague-Dawley rats. Intravenous infusion of E. coli caused arteriolar constriction to 83 +/- 4% of baseline (BL) in cortical radial arteries (CRA), 82 +/- 3% of BL in afferent (AFF) arterioles, and decreased flow to 54 +/- 9% of BL. Subsequent local inhibition of renal prostaglandin synthesis with mefenamate increased preglomerular arteriolar constriction to 55 +/- 6% of BL in CRA and 51 +/- 6% of BL in AFF arterioles and decreased renal microvascular blood flow to 26 +/- 8% of BL values in E. coli animals but had no effect on control animals. Subsequent local renal angiotensin II receptor blockade with saralasin acetate increased renal microvascular blood flow in E. coli animals to 64 +/- 9% of BL by dilating CRA to 78 +/- 5% of BL and AFF arterioles to 89 +/- 5% of BL. Phentolamine caused further dilation of CRA to 104 +/- 7% BL and AFF arterioles to 116 +/- 109% and increased flow to 99 +/- 8% of BL. Acetylcholine increased diameters further to 110 +/- 3% of BL in CRA and 136 +/- 12% of BL in AFF arterioles. These data indicate that in our chronic hydronephrotic kidney model during E. coli bacteremia, renal microvascular tone is due to increased angiotensin II and alpha-adrenergic activity and some other, as yet, undefined factor.
Cryer
H G
HG
Department of Surgery, University of California, Los Angeles 90024.
Bloom
I T
IT
Unger
L S
LS
Garrison
R N
RN
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D016470:Bacteremia / Q000503:physiopathology*; D004927:Escherichia coli Infections / Q000503:physiopathology*; D008297:Male; D008528:Mefenamic Acid / Q000494:pharmacology; D008833:Microcirculation / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects; D012504:Saralasin / Q000494:pharmacology
D008528:Mefenamic Acid; D012504:Saralasin; D000109:Acetylcholine; D010646:Phentolamine